Jurij Lindtner

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 565 citations

Medicine, Oncology, Surgery +17

Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials

Bernhard C. Pestalozzi, David Zahrieh, Elizabeth Mallon et al. · Journal of Clinical Oncology · 2008 · 497 citations · Full text

Medicine, Oncology, Surgery +9

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)

Bernhard C. Pestalozzi, David Zahrieh, Karen N. Price et al. · Annals of Oncology · 2006 · 412 citations · Full text

Medicine, Neurology, Oncology +16

Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII

Diana Crivellari, Marco Bonetti, Monica Castiglione‐Gertsch et al. · Journal of Clinical Oncology · 2000 · 295 citations

Medicine, Oncology, Pharmacology +15

Risk Factors for Locoregional Recurrence Among Breast Cancer Patients: Results From International Breast Cancer Study Group Trials I Through VII

Arne Wallgren, Marco Bonetti, Richard D. Gelber et al. · Journal of Clinical Oncology · 2003 · 273 citations

Medicine, Oncology, Breast Oncology +16